Φορτώνει......
Acetylcholinesterase inhibitor treatment for myasthenia gravis
BACKGROUND: In myasthenia gravis, antibody‐mediated blockade of acetylcholine receptors at the neuromuscular junction abolishes the naturally occurring ‘safety factor’ of synaptic transmission. Acetylcholinesterase inhibitors provide temporary symptomatic treatment of muscle weakness but there is co...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cochrane Database Syst Rev |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Ltd
2014
|
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7390275/ https://ncbi.nlm.nih.gov/pubmed/25310725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006986.pub3 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|